Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China.

ABSTRACT:

Background

Coronavirus Disease 2019 (COVID-19) is an emerging and rapidly evolving disease, with no recommended effective anti-coronavirus drug treatment. Traditional Chinese Patent Medicines (CPMs) have, however, been widely used to treat COVID-19 in China, and a number of clinical practice results have shown them to have a significant role in its treatment. Consequently, numerous guidelines and expert consensus have recommended the use of CPMs to treat COVID-19.

Aim of the study

The objectives of this review are to provide up-to-date information on the pharmacology and clinical research on CPMs in the treatment of COVID-19, discuss the research findings, and to better guide clinical application and scientific research on CPMs in the treatment of COVID-19.

Methods

Th

SUBMITTER: Zhuang W 

PROVIDER: S-EPMC7396557 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature